NMR Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells. Radiol Oncol [Internet]. 2018 Dec. 17 [cited 2026 Sep. 22];52(4). Available from: https://radioloncol.com/index.php/ro/article/view/2963